Dernières actus

Pound Falls on Disappointing UK Jobs Data as Dollar Gains Strength
Sterling dropped after UK private-sector payrolls fell 34,000 in August, while the dollar index approached 100 ahead of Wednesday's Federal Reserve decision.

FTSE 100 falls as oil rises and AI safety dispute clouds markets
European and U.S. shares eased as Brent crude climbed on a Saudi pipeline outage, while AI leaders clashed over development speed and UK labour data showed cooling pay growth.

UBS Shares Fall 4.7% After Bank of America Flags Flat Trading Revenues
UBS shares dropped as much as 4.7% to 41.31 francs after Bank of America CEO Brian Moynihan forecast relatively stable Q3 trading revenues, raising concerns about the Swiss bank's record trading performance.

Swiss stocks fall after open; UBS, Partners Group and SMG drop
SMI opens 0.55% lower as UBS and Partners Group fall, SMG drops after ownership changes, Centiel rises, and oil gains ahead of the Fed decision.

DAX expected to hold after weak start as oil and Fed decision draw focus
The X-Dax points to a flat DAX open at 25,454 after Monday's 0.5% decline, while elevated oil prices and a likely Fed tightening decision shape the session.

BX Digital rebrands as SeturionX under Boerse Stuttgart Group
The Swiss Finma-licensed DLT trading system will integrate with Boerse Stuttgart's pan-European Seturion settlement platform while keeping settlement processes in Switzerland.

Macro calendar: ZEW, ADP, Empire State among key data releases Monday
The German ZEW survey, UK jobs data, French consumer prices, and US ADP and Empire State manufacturing reports round out the Monday schedule.

Swiss Economic Calendar: Data Releases, Earnings Due Sept 15-22
Switzerland’s weekly financial calendar features Austrian and Swiss inflation data, SNB balance-of-payments figures, and H1 earnings from Addex, Curatis, Newron and others.
SMI set lower as oil rises and AI-security fears pressure chip stocks
Swiss SMI is set to open 0.26% lower as Middle East tensions lift oil and AI-security concerns weigh on chip stocks, while the dollar gains against the franc.

US stocks set for mixed open as oil nears $100 and rate-hike odds rise
Dow seen 0.8% lower at 53,013 and Nasdaq 100 0.1% higher at 29,568, while Brent tops $98 and ECB and US rate-hike expectations weigh on sentiment.

Wall Street Opens Lower as Oil Surge Weighs; Nasdaq Edges Up on AI Stocks
Dow fell ~1% to 52,885 and S&P 500 dropped 0.4% to 7,690 on rising oil prices ahead of an ECB rate move; Nasdaq 100 gained 0.1% to 29,578 as AI-related shares offset weakness.

DAX Flat as Oil Hits $100; Fresenius, Kion Lead Gains
The DAX stalled near 26,007 as Brent approached $100 a barrel on Middle East supply fears. Fresenius and Kion led gains while Infineon fell 4% on a Morgan Stanley downgrade.

Best-Performing Dividend ETFs Over the Past Decade: US and Swiss Comparisons
YCharts ranks three US dividend ETFs among the top performers of the past decade, while Swiss-listed funds from UBS and BlackRock offer lower-cost alternatives with concentrated SMI exposure.

European Stocks Close Mixed; Novartis Slump Drag on Swiss SMI
The EuroStoxx 50 edged higher while the Swiss SMI fell 1.55% weighed down by Novartis, as investors waited on the ECB rate decision and Brent crude neared $100 a barrel.

European stocks little changed ahead of ECB and US inflation data
EuroStoxx 50 rose 0.17% to 6,403.99 as investors awaited Thursday's ECB decision and Friday's US inflation print, while oil shares gained on Gulf tensions.

SMI closes at session low as Novartis posts biggest daily loss ever
The Swiss benchmark fell 1.55% to 14,047, dragged by Novartis (-10.9%) after a Phase III study failure. UBS rose to a 19-year high above 45 francs.

Nestlé says growth reset gains pace as RIG improves to 1.8% in Q2
Nestlé CFO Anna Manz said real internal growth accelerated from 1.2% in Q1 to 1.8% in Q2, with H1 cost savings of CHF 600 million and UTOP margins expected above 17%.

US stocks fall as oil nears $100; Novartis posts steep loss
US indices slipped on higher oil prices and rate-hike concerns, while Novartis fell 9.8% after another trial disappointment and the SMI stayed near its low.

Novartis plunges as oil and rate worries push US and Swiss stocks lower
Novartis fell more than 9% after a phase-III miss, dragging the SMI lower as US stocks slipped on rising oil prices and rate-hike expectations.

US Markets Slide as Oil Hits $98; Novartis Plunges Toward Record Loss
Brent crude climbs toward $100 on Middle East tensions, weighing on Wall Street and Switzerland's SMI. Novartis falls nearly 10% after Phase III trial miss, wiping out roughly CHF 24 billion in market value.

US Markets Mixed After Holiday; Oil Weighs on Sentiment as Novartis Plunges
Dow futures sink 0.8% as Brent crude approaches $100; Novartis shares tumble over 9% after second clinical miss hits Swiss index.

Confidence Prevails at Structured Products Forum in Interlaken
The International Structured Products Forum in Interlaken saw an optimistic tone driven by strong market performance, while speakers addressed regulatory challenges in Switzerland and the EU.

Dax slips as Brent crude nears $100 and oil prices pressure German stocks
The Dax fell to 25,975 in early afternoon trade as Brent crude approached $100 and WTI and European gas prices rose, while stock-specific ratings drove moves in Dax and MDax names.

US Stocks Expected to Open Mixed After Holiday; Oil Prices Pressuring Sentiment; SMI Continues Decline; Novartis Targets Record Daily Loss
US stock indices show slight movements before market open; oil prices rise, fueling concerns over rising interest rates; Swiss Market Index (SMI) continues to fall; Novartis shares plunge, potentially setting a record daily loss.

